Program: Education Program
Session: How Can We Manage High-Risk Hematologic Malignancies in the Community?
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality)
Session: How Can We Manage High-Risk Hematologic Malignancies in the Community?
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality)
Monday, December 11, 2023, 4:30 PM-5:45 PM
Disclosures: Patel-Donnelly: Boston Biomed: Research Funding; Gilead: Research Funding; LAM Therapeutics: Research Funding; Roche: Research Funding; American Board of Internal Medicine (ABIM): Other: American Board of Internal Medicine (ABIM).
See more of: How Can We Manage High-Risk Hematologic Malignancies in the Community?
See more of: Education Program
See more of: Education Program
Previous Presentation
|
Next Presentation >>